Mettler-Toledo International (MTD) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Q2 2026 delivered strong results with 4% reported sales growth to $1.03 billion and 6% local currency growth, driven by robust organic sales in China and emerging markets, and supported by productivity and innovation initiatives.
Adjusted EPS for Q2 2026 was $11.46, up 14% year-over-year; reported EPS was $11.55, including a $52 million one-time tariff refund benefit.
Segment profit rose, notably in China and the U.S., reflecting margin expansion and higher sales.
Strategic initiatives in sales, marketing, and productivity contributed to financial outperformance.
Six-month reported sales increased 6% year-over-year to $2.0 billion; adjusted EPS for the period was $20.35, up 11%.
Financial highlights
Q2 2026 net sales reached $1.03 billion, up 4% year-over-year; adjusted gross margin was 59.3% (63.3% including one-time items), and adjusted operating profit was $309 million, up 9% year-over-year.
Adjusted EPS for Q2 2026 was $11.46, a 14% increase; reported EPS was $11.55, including a $0.92 net tariff refund benefit.
Operating cash flow for the first half of 2026 was $450.2 million; adjusted free cash flow YTD was $367 million.
Q2 2026 earnings before taxes were $289.4 million, up from $248.7 million in Q2 2025.
Gross profit margin for Q2 2026 was 63.3% (59.3% excluding one-time items); operating margin was 29.3% (adjusted).
Outlook and guidance
Full-year 2026 local currency sales growth expected at 4–5% (excluding tariff refunds); adjusted EPS guidance raised to $47.15–$47.50, up 10–11%.
Q3 2026 local currency sales expected to grow ~4%; adjusted EPS guidance is $12.00–$12.15.
Free cash flow expected at $900 million for 2026, up 6% per share; share repurchases to increase to $875 million for the year.
Management remains focused on automation, digitalization, and onshoring trends to drive growth.
Ongoing investments in digital tools, product innovation, and field organization are expected to support future performance.
Latest events from Mettler-Toledo International
- Strong Q1 growth, tariff mitigation, and margin initiatives position the business for resilience.MTD
Bank of America 2025 Healthcare Conference - Strong earnings, innovation, and China-led growth support a positive second-half outlook.MTD
Bank of America Global Healthcare Conference 2026 - Adjusted EPS up 9% and sales up 7% in Q1 2026, with raised full-year EPS guidance.MTD
Q1 2026 - Q4 2025 delivered 8% sales and EPS growth, with a strong outlook for 2026.MTD
Q4 2025 - 2026 guidance targets 4% revenue growth, margin expansion, and full tariff mitigation.MTD
44th Annual J.P. Morgan Healthcare Conference - Q3 2025 delivered strong sales and EPS growth, with innovation and resilience amid tariff headwinds.MTD
Q3 2025 - Q2 sales fell 4% but net earnings rose 4% and full-year EPS guidance was raised.MTD
Q2 2024 - Q1 sales fell 5% to $883.7M, but margin gains and lab growth offset tariff headwinds.MTD
Q1 2025 - Q4 2024 saw double-digit sales and EPS growth, with 2025 guidance tempered by headwinds.MTD
Q4 2024